Assistant Professor of Psychiatry and Behavioral Health
Department of Psychiatry and Behavioral Health
Office: 631-638-3154
Email: MinJeong.Kim@stonybrookmedicine.edu
Department of Psychiatry and Behavioral Health
Health Sciences Center T10-041L
Education
PhD, Neuroscience, Seoul National University, 2011
MS, Neuroscience, Seoul National University, 2005
MD, Seoul National University College of Medicine, 2001
Training/Employment
| 2018 - 2020 | Clinical Fellow, Molecular Imaging Branch, National Institute of Mental Health |
| 2015 - 2018 | Postdoctoral Visiting Fellow, Molecular Imaging Branch, National Institute of Mental Health |
| 2012 - 2015 | Clinical Assistant Professor of Neurology, Seoul National University Hospital Gangnam Center |
| 2009 - 2010 | Clinical Fellow of Dementia and Behavioral Neurology, Samsung Medical Center |
| 2007 - 2009 | Chief Neurologist, National Police Hospital |
| 2002 - 2007 | Neurology Residency and Fellowship, Seoul National University Hospital |
Research
Dr. Kim’s earlier research before 2015 was focused on understanding the disease mechanisms of Alzheimer’s disease and related dementias using clinical neuroimaging methods such as MRI and [18F]FDG PET. Between 2015 and 2020, she conducted translational PET research using novel radioligands targeting key molecules of neuroinflammation at the National Institute of Mental Health. Since she moved to Stony Brook University in 2020, she has been focusing on PET imaging studies primarily in the aging population, including patients with Alzheimer’s disease and related dementias.
Honors/Awards
| 2021 | The Mitzi & William Blahd, MD, Pilot Research Grant, Society of Nuclear Medicine and Molecular Imaging |
| 2020 | The Fellows Award for Research Excellence, National Institutes of Health |
| 2019 | The Alavi-Mandell Award for publication in Journal of Nuclear Medicine, Society of Nuclear Medicine and Molecular Imaging |
| 2017 | Young Professional Award for the best abstract in basic science, Society of Nuclear Medicine and Molecular Imaging |
| 2010 | Travel fellowship award, International Conference on Alzheimer’s Disease |
| 2004 | Young Investigator Award, World Stroke Congress |
Representative Publications
- Taddei C, Morse CL, Kim MJ, Liow JS, Montero Santamaria J, Zhang A, Manly LS, Zanotti-Fregonara P, Gladding RL, Zoghbi SS, Innis RB, Pike VW. Synthesis of [18F]PS13 and Evaluation as a PET Radioligand for Cyclooxygenase-1 in Monkey. ACS Chem Neurosci. 2021 Feb 3;12(3):517-530.
- Kim MJ, Lee JH, Juarez Anaya F, Hong J, Miller W, Telu S, Singh P, Cortes MY, Henry K, Tye GL, Frankland MP, Montero Santamaria JA, Liow JS, Zoghbi SS, Fujita M, Pike VW, Innis RB. First-in-human evaluation of [11C]PS13, a novel PET radioligand, to quantify cyclooxygenase-1 in the brain. Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3143-3151.
- Meyer JH, Cervenka S, Kim MJ, Kreisl WC, Henter ID, Innis RB. Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry. 2020 Dec;7(12):1064-1074.
- Kreisl WC, Kim MJ, Coughlin JM, Henter ID, Owen DR, Innis RB. PET imaging of neuroinflammation in neurological disorders. Lancet Neurol. 2020 Nov;19(11):940-950.
- Shrestha S*, Kim MJ*, Eldridge M, Lehmann ML, Frankland M, Liow JS, Yu ZX, Cortes-Salva M, Telu S, Henter ID, Gallagher E, Lee JH, Fredericks JM, Poffenberger C, Tye G, Ruiz-Perdomo Y, Anaya FJ, Montero Santamaria JA, Gladding RL, Zoghbi SS, Fujita M, Katz JD, Pike VW, Innis RB. PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study. J Neuroinflammation. 2020 May 2;17(1):140. *Co-first authors.
- Kim MJ, McGwier M, Jenko KJ, Snow J, Morse C, Zoghbi SS, Pike VW, Innis RB, Kreisl WC. Neuroinflammation in frontotemporal lobar degeneration revealed by 11C-PBR28 PET. Ann Clin Transl Neurol. 2019 Jul;6(7):1327-1331.
- Kim MJ, Shrestha SS, Cortes M, Singh P, Morse C, Liow JS, Gladding RL, Brouwer C, Henry K, Gallagher E, Tye GL, Zoghbi SS, Fujita M, Pike VW, Innis RB. Evaluation of Two Potent and Selective PET Radioligands to Image COX-1 and COX-2 in Rhesus Monkeys. J Nucl Med. 2018 Dec;59(12):1907-1912.
- Shrestha S, Singh P, Cortes-Salva MY, Jenko KJ, Ikawa M, Kim MJ, Kobayashi M, Morse CL, Gladding RL, Liow JS, Zoghbi SS, Fujita M, Innis RB, Pike VW. 3-Substituted 1,5-Diaryl-1 H-1,2,4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 2: Selection and Evaluation of [11C]PS13 for Quantitative Imaging. ACS Chem Neurosci. 2018 Nov 21;9(11):2620-2627.
- Hong YJ, Kim MJ, Jeong E, Kim JE, Hwang J, Lee JI, Lee JH, Na DL. Preoperative biomarkers in patients with idiopathic normal pressure hydrocephalus showing a favorable shunt surgery outcome. J Neurol Sci. 2018 Apr 15;387:21-26.
- Kim MJ, Seo SW, Kim ST, Lee JM, Na DL. Diffusion Tensor Changes According to Age at Onset and Apolipoprotein E Genotype in Alzheimer Disease. Alzheimer Dis Assoc Disord. 2016 Oct-Dec;30(4):297-304
- Kim MJ, Seo SW, Kim GH, Kim ST, Lee JM, Qiu A, Na DL. Less depressive symptoms are associated with smaller hippocampus in subjective memory impairment. Arch Gerontol Geriatr. 2013 Jul-Aug;57(1):110-5
- Kim MJ, Lee KM, Son YD, Jeon HA, Kim YB, Cho ZH. Increased basal forebrain metabolism in mild cognitive impairment: an evidence for brain reserve in incipient dementia. J Alzheimers Dis. 2012;32(4):927-38.